Activating Clinical Trial Sites Quickly During COVID-19 Lockdowns
A sponsor needed to enroll at least 200 patients for a pivotal Phase IIIb clinical trial — right when the…
Missed Revenue in Clinical Research: 1 Study, 10 Sites, $154,000 Caught
Whether from faulty sponsor payment systems, incomplete invoicing, or other causes, private practice investigational sites routinely miss out on significant…
Frenova Helps With Business, Allows Principal Investigator to Focus on Care
Clinical investigators regularly report that logistical barriers hinder their conduct of clinical trials. Physician and staff workload balance, the time…
Case Study: Rescuing Troubled Sites
For a clinical study managed by another CRO, Frenova had to identify and correct the consequences of poor monitoring by…
Vifor Case Study: A Pivotal Phase III Study for FDA Approval of Velphoro® (Sucroferric Oxyhydroxide), a Hyperphosphatemia Medication
Enrolling patients affected by chronic kidney disease can be particularly challenging. With multiple comorbidities, they are often reluctant to undergo…
Maximizing Site Performance From Problematic to Top Performing: Frenova’s Site Strategy for Efficient Clinical Research
An investigator site faced numerous challenges managing studies and experienced ongoing issues with finance, communication, and operations. The site staff…